Skip header and navigation

10 records – page 1 of 1.

Safety of genetically modified organisms

https://policybase.cma.ca/en/permalink/policy378
Date
1999-Aug-25
Topics
Health care and patient safety
Resolution
That the Canadian Medical Association ask Health Canada to ensure it obtains sound evidence of the safety of genetically modified organisms before they are authorized by Agriculture and Agri-Food Canada.
Policy Type
Policy resolution
Last Reviewed
2013-Mar-02
Date
1999-Aug-25
Topics
Health care and patient safety
Resolution
That the Canadian Medical Association ask Health Canada to ensure it obtains sound evidence of the safety of genetically modified organisms before they are authorized by Agriculture and Agri-Food Canada.
Less detail

Regulations for genetically modified organisms

https://policybase.cma.ca/en/permalink/policy380
Date
1999-Aug-25
Topics
Health care and patient safety
Resolution
That the Canadian Medical Association urge the federal government to act quickly to adopt regulations controlling the development, testing and commercialization of genetically modified organisms.
Policy Type
Policy resolution
Last Reviewed
2013-Mar-02
Date
1999-Aug-25
Topics
Health care and patient safety
Resolution
That the Canadian Medical Association urge the federal government to act quickly to adopt regulations controlling the development, testing and commercialization of genetically modified organisms.
Less detail

Putting Patients First : Comments on Bill C 6 (Personal Information Protection and Electronic Documents Act) : Submission to the Senate Standing Committee on Social Affairs, Science and Technology

https://policybase.cma.ca/en/permalink/policy1979
Date
1999-Nov-25
Topics
Ethics and medical professionalism
Health care and patient safety
Health information and e-health
  2 documents  

Listening to our Patient's Concerns : Comments on Bill C 54 (Personal Information Protection and Electronic Document Act) : Submission to the House of Commons Standing Committee on Industry

https://policybase.cma.ca/en/permalink/policy1980
Date
1999-Mar-18
Topics
Health care and patient safety
Health information and e-health
Ethics and medical professionalism
  2 documents  

Response to Health Canada’s Discussion Papers on “Proposed New Labelling Requirements for Tobacco Products” and “Options for Tobacco Promotion Regulations”

https://policybase.cma.ca/en/permalink/policy1982
Date
1999-Mar-12
Topics
Health care and patient safety
Population health/ health equity/ public health
  1 document  

Proposed Amendments to the Criminal Code of Canada (Impaired Driving) : Response to Issue Paper of the Standing Committee on Justice and Human Rights

https://policybase.cma.ca/en/permalink/policy1983
Date
1999-Mar-05
Topics
Health care and patient safety
Population health/ health equity/ public health
  2 documents  

Child restraint systems

https://policybase.cma.ca/en/permalink/policy734
Date
1991-Aug-15
Topics
Health care and patient safety
Resolution
That the Canadian Medical Association actively promote to all levels of government concerns regarding child safety, particularly in relation to the requirement for child restraint safety systems in all types of motor vehicles in which children routinely travel.
Policy Type
Policy resolution
Last Reviewed
2016-May-20
Date
1991-Aug-15
Topics
Health care and patient safety
Resolution
That the Canadian Medical Association actively promote to all levels of government concerns regarding child safety, particularly in relation to the requirement for child restraint safety systems in all types of motor vehicles in which children routinely travel.
Less detail

Smoking and radon

https://policybase.cma.ca/en/permalink/policy735
Date
1991-Aug-15
Topics
Health care and patient safety
Resolution
The Canadian Medical Association recognizes that radon levels greater than 150 Bq/m3 are hazardous and recommends that Health Canada advise Canadians concerning this risk, make recommendations for measuring and reducing radon levels where appropriate, and remind Canadians that smoking increases a person's risk of lung cancer due to radon exposure.
Policy Type
Policy resolution
Last Reviewed
2016-May-20
Date
1991-Aug-15
Topics
Health care and patient safety
Resolution
The Canadian Medical Association recognizes that radon levels greater than 150 Bq/m3 are hazardous and recommends that Health Canada advise Canadians concerning this risk, make recommendations for measuring and reducing radon levels where appropriate, and remind Canadians that smoking increases a person's risk of lung cancer due to radon exposure.
Less detail

Adverse reactions between alcohol and drug products

https://policybase.cma.ca/en/permalink/policy805
Date
1987-Aug-25
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
1987-Aug-25
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
Less detail

Drug product substitution

https://policybase.cma.ca/en/permalink/policy806
Date
1987-Aug-25
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
The Canadian Medical Association supports the position that: 1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and 2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
1987-Aug-25
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
The Canadian Medical Association supports the position that: 1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and 2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
Less detail

10 records – page 1 of 1.